Efficacy and immunological correlates of an mRNA-LNP vaccine for protection against an emerging rickettsial pathogen
Authors:
Open Access
- 30 March 2026
- journal article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 15 (1) , 2645860
Abstract
A rickettsial pathogen Ehrlichia chaffeensis causes emerging tick-borne disease called human monocytic ehrlichiosis (HME). E. chaffeensis in ticks expresses a porin OMP-1B, the immunodominant major outer membrane protein, which is required for nutrient uptake across outer membrane of bacteria. We developed an OMP-1B-encoding mRNA-lipid nanoparticle (hereafter OMP-1B mRNA-LNP) vaccine. Immunization of naïve mice with OMP-1B mRNA-LNP showed significant protection against E. chaffeensis infection following challenge with E. chaffeensis-infected tick cells. Following vaccination, increased OMP-1B-specific serum IgG, IgG1, and IgG2a titers, and E. chaffeensis infection-neutralizing antibodies were detected. An ELISpot assay revealed significant increase in OMP-1B-specific IFN-γ-secreting cells in the blood and spleen samples from mice vaccinated with OMP-1B mRNA-LNP. Flow cytometry analysis of spleen samples showed OMP-1B antigen-specific IFN-γ-producing CD4+ and CD8+ T cells and granzyme B-producing cytotoxic CD8+ T cells were significantly increased in the vaccinated mice. Our results demonstrate that an mRNA vaccine targeting OMP-1B conferred protection against E. chaffeensis infection, with significant humoral immune responses including infection-neutralizing antibodies, balanced Th1/Th2 response, and antigen-specific T helper and cytotoxic T cell activation. These data suggest mRNA-LNP approach is a viable strategy for developing efficient anti-rickettsial vaccines.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI152223)
This publication has 58 references indexed in Scilit:
- Development of Etf-3-specific nanobodies to prevent Ehrlichia infection and LNP-mRNA delivery in cellular and murine modelsMicrobiological Research, 2024
- Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinicsAdvanced Drug Delivery Reviews, 2023
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNAMolecular Therapy Nucleic Acids, 2019
- IL-17+ γδ T cells as kick-starters of inflammationNature Immunology, 2017
- IgG subclass co‐expression brings harmony to the quartet model of murine IgG functionImmunology & Cell Biology, 2016
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesJournal of Controlled Release, 2015
- Inhibitory effect of interferon gamma on frequency of Ehrlichia canis-infected cells in vitroVeterinary Immunology and Immunopathology, 2013
- Natural History of Ehrlichia chaffeensis: Vertebrate hosts and tick vectors from the United States and evidence for endemic transmission in other countriesVeterinary Parasitology, 2010
- The realities of biodefense vaccines against RickettsiaVaccine, 2009
- Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamiliesJournal of Leukocyte Biology, 1996